Legal & General Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.4M | Buy |
|
|||||
|
2025
Q1 | $12M | Sell |
|
|||||
|
2024
Q4 | $10.9M | Buy |
|
|||||
|
2024
Q3 | $12.1M | Buy |
|
|||||
|
2024
Q2 | $11.9M | Buy |
|
|||||
|
2024
Q1 | $3.48M | Buy |
|
|||||
|
2023
Q4 | $2.37M | Sell |
|
|||||
|
2023
Q3 | $2.27M | Buy |
|
|||||
|
2023
Q2 | $2.2M | Buy |
|
|||||
|
2023
Q1 | $740K | Buy |
|
|||||
|
2022
Q4 | $564K | Buy |
|
|||||
|
2022
Q3 | $485K | Buy |
|
|||||
|
2022
Q2 | $431K | Buy |
|
|||||
|
2022
Q1 | $435K | Buy |
|
|||||
|
2021
Q4 | $432K | Buy |
|
|||||
|
2021
Q3 | $293K | Buy |
|
|||||
|
2021
Q2 | $189K | Buy |
|
|||||
|
2021
Q1 | $206K | Buy |
|
|||||
|
2020
Q4 | $144K | Hold |
|
|||||
|
2020
Q3 | $102K | Sell |
|
|||||
|
2020
Q2 | $113K | Buy |
|
|||||
|
2020
Q1 | $107K | Sell |
|
|||||
|
2019
Q4 | $163K | Buy |
|
|||||
|
2019
Q3 | $88K | Buy |
|
|||||
|
2019
Q2 | $59K | Buy |
|